BCL2 and non-small cell lung carcinoma: BCL2 is also a direct target of miR-1290 and miR-206 in non-small cell lung cancer (NSCLC) [103,106], with miR-1290 mediated silencing of BCL2 has been reported to regulate the apoptotic effect to asiatic acid—a putative anti-cancer agent—in A549 cells [106].